🧠 This Week in Immunology: Pediatric Crohn’s Breakthroughs, Dupixent Approval, and more Advancements in Autoimmune Therapies
Stay up to date with the latest developments in immunology—from pediatric treatments and autoimmune therapy innovations to real-world data and strategic partnerships in the field:
💥 Johnson & Johnson Seeks FDA Approval for pediatric Crohn’s treatment, supported by Phase 3 UNITI-Jr data, addressing the increasing need in pediatric patients.
🏅 CreakyJoints Dominates Social Media at the European Rheumatology Conference, surpassing 62,000 views and featuring 12 interviews with top rheumatologists and patient advocates.
🤔 Geneoscopy’s ColoSense Validates Impact in colorectal cancer screening, showing a 14 to 23 percent reduction in CRC deaths and now included in the 2025 NCCN guidelines.
🇪🇺 Emrosi Data to be Presented at SDPA 2025 Dermatology Conference, with strong efficacy for rosacea treatment, independent of body weight, simplifying patient management.
💉 FDA Approves Dupixent for Bullous Pemphigoid treatment, the first targeted therapy for this autoimmune skin disorder in adults, based on ADEPT trial success.
🧬 Real-World Efficacy of Upadacitinib and Abrocitinib in atopic dermatitis, showing significant improvements after one year with no new safety concerns.
💡 argenx Announces VYVGART Approval for CIDP in Europe, marking the first new treatment for this rare autoimmune condition in over 30 years.
🌍 Candid Therapeutics Advances T-Cell Engagers for autoimmune diseases, including ongoing clinical trials for conditions like rheumatoid arthritis and lupus.
🔬 Immutep Announces Positive Phase I Data for IMP761, a promising LAG-3 agonist antibody showing effective T-cell suppression without adverse effects.
🧪 AltruBio Presents Data for ALTB-268 in T-cell mediated inflammatory diseases, showing efficacy in animal models of colitis and graft-versus-host disease.
🌐 Harbour BioMed Partners with Otsuka to develop BCMAxCD3 bispecific T-cell engagers, advancing new treatments for autoimmune diseases.
📢 Stay Ahead in Immunology Research!
✅ Like, share, and subscribe for weekly updates on the latest in immunology and autoimmune innovation
#Immunology #FDAApproval #PediatricCrohns #BullousPemphigoid #AutoimmuneDiseases #AtopicDermatitis #ColorectalCancer #ImmunologyResearch #Rheumatology #ClinicalTrials #Biotech #LucidQuest #ImmunologyUpdates #HealthcareInnovation